Psychosocial predictors of survival in metastatic melanoma

被引:103
作者
Butow, PN
Coates, AS
Dunn, SM
机构
[1] Royal Prince Alfred Hosp, Sydney Melanoma Unit, Camperdown, NSW, Australia
[2] Univ Sydney, Med Psychol Unit, Sydney, NSW 2006, Australia
[3] Univ Sydney, Dept Canc Med, Sydney, NSW 2006, Australia
关键词
D O I
10.1200/JCO.1999.17.7.2256
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Research interest in psychosocial predictors tars Of the onset and course of cancer has been active since the 1950s, However, results have been contradictory and the literature is noted for methodologic weaknesses, In this prospective study, we aimed to systematically obtain data on psychosocial factors associated with human response to illness. Patients and Methods: One hundred twenty-five patients with metastatic melanoma completed questionnaires measuring cognitive appraisal of threat, coping, psychologic adjustment, perceived aim of treatment, social support, and quality of life (QOL). Questionnaires were completed, where possible, every 3 months for 2 years after diagnosis. Survival was measured from date of study entry to date of death or was censored at the date of last follow-up for surviving patients. Results: In a multivariate Cox regression analysis of baseline data, which controlled for demographic and disease predictors, the psychologic variables of perceived aim of treatment (P < .001), minimization (P < .05), and anger (P < .05) were independently predictive of survival, Patients who were married (P < .01) and who reported a better QOL (P < .05) also survived longer. Conclusion: The prognostic significance of psychologic and QOL scores remained after allowance for conventional prognostic factors. If these associations reflect an early perception by the patient or doctor of disease progression, then measures are at least valuable early indicators of such progression. If psychologic processes have a more direct influence on the course of the underlying illness, then it may be! possible to manipulate them for therapeutic effect. We are now conducting a randomized controlled trial of a psychologic intervention to further elucidate these issues. (C) 1999 by American Society of Clinical Oncology.
引用
收藏
页码:2256 / 2263
页数:8
相关论文
共 36 条
  • [1] ON THE RECEIVING END .4. VALIDATION OF QUALITY-OF-LIFE INDICATORS
    BUTOW, P
    COATES, A
    DUNN, S
    BERNHARD, J
    HURNY, C
    [J]. ANNALS OF ONCOLOGY, 1991, 2 (08) : 597 - 603
  • [2] CARVER CS, 1994, CANCER, V73, P1213, DOI 10.1002/1097-0142(19940215)73:4<1213::AID-CNCR2820730415>3.0.CO
  • [3] 2-Q
  • [4] PSYCHOSOCIAL CORRELATES OF CANCER SURVIVAL - A SUBSEQUENT REPORT 3 TO 8 YEARS AFTER CANCER-DIAGNOSIS
    CASSILETH, BR
    WALSH, WP
    LUSK, EJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (11) : 1753 - 1759
  • [5] ON THE RECEIVING END .3. MEASUREMENT OF QUALITY OF LIFE DURING CANCER-CHEMOTHERAPY
    COATES, A
    GLASZIOU, P
    MCNEIL, D
    [J]. ANNALS OF ONCOLOGY, 1990, 1 (03) : 213 - 217
  • [6] PROGNOSTIC VALUE OF QUALITY-OF-LIFE SCORES IN A TRIAL OF CHEMOTHERAPY WITH OR WITHOUT INTERFERON IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA
    COATES, A
    THOMSON, D
    MCLEOD, GRM
    HERSEY, P
    GILL, PG
    OLVER, IN
    KEFFORD, R
    LOWENTHAL, RM
    BEADLE, G
    WALPOLE, E
    [J]. EUROPEAN JOURNAL OF CANCER, 1993, 29A (12) : 1731 - 1734
  • [7] SYSTEMIC CHEMOTHERAPY FOR MALIGNANT-MELANOMA
    COATES, AS
    [J]. WORLD JOURNAL OF SURGERY, 1992, 16 (02) : 277 - 281
  • [8] LONG-TERM RESPONSE TO CHEMOTHERAPY IN PATIENTS WITH VISCERAL METASTATIC MELANOMA
    COATES, AS
    SEGELOV, E
    [J]. ANNALS OF ONCOLOGY, 1994, 5 (03) : 249 - 251
  • [9] COX DR, 1972, J R STAT SOC B, V34, P187
  • [10] PSYCHOLOGICAL COPING MECHANISMS AND SURVIVAL TIME IN METASTATIC BREAST-CANCER
    DEROGATIS, LR
    ABELOFF, MD
    MELISARATOS, N
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 242 (14): : 1504 - 1508